Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

1. O'B Hourihane, J.
2. Beyer, K.
3. Abbas, A.
4. Fernández-Rivas, M.
5. Turner, P.J.
6. Blumchen, K.
7. Nilsson, C.
8. Ibáñez, M.D.
9. Deschildre, A.
10. Muraro, A.
11. Sharma, V.
12. Erlewyn-Lajeunesse, M.
13. Zubeldia, J.M.
14. De Blay, F.
15. Sauvage, C.D.
16. Byrne, A.
17. Chapman, J.
18. Boralevi, F.
19. DunnGalvin, A.
20. O'Neill, C.
21. Norval, D.
22. Vereda, A.
23. Skeel, B.
24. Adelman, D.C.
25. du Toit, G.